HIB 73%II 27% (37.1%) II A+C 57.1%34.9% 28.0%47.6%

1 2 1 18.0%23.4%6.9% 10.7% 1 8.7% 1 II 64% II54% 79%72% 3 2 26,5003,500 90070% 4 1,250 10150020% 4 1 Frost & Sullivan II II II II 2 Frost & Sullivan 3 Frost & Sullivan 4

1915 6 HIB 73%II 27% (37.1%) II A+C 57.1%34.9% 28.0%47.6%

MENET 3 42.9%65.1% 53.8%86.3% 53.8% IMS 7015 3 MENET

23 23 III II II64% I20.7%II24.4% 31.3%39.3% 4 930.41,479.81,524.6 28.0% 4 Frost & Sullivan

II15.2% 74 Frost & SullivanII 7.6% 33297 99396

1,414.02,395.0 2,668.0 %... 1,413,985 2,395,038 2,667,978 37.4... 841,334 1,230,340 1,167,767 17.8... 89,093 249,447 356,788 100.1... 184,059 625,493 838,562 113.4... 299,499 289,758 304,861 0.9... 87,690 192,385 255,537 70.7 1... 40,626 47,100 44,970 5.2... 9,771 60,216 64,888 157.7... 46,220 103,399 194,741 105.3... 12,862 13,119 10,255 (10.7) 1 II 12.9% 8,500

I14 IIII 20.7%II24.4% II64% II IMS 2010 IMS70 15 Frost & Sullivan 0.4%8.7% 5 Frost & SullivanII 18.0%23.4% 6 28.0% 5 Frost & Sullivan II II 6 Frost & Sullivan II II

II15.2% 4.0% 10.7% 16.6% 24.9% 118.611% 142.213% 2,80020,500 90% 3804,000 48 7 Frost & Sullivan

(Jiangsu Pharmaceutical Quality Control Society) 7 33297 590% II37.1% II54% II 22%480 7 Frost & Sullivan

A+C90 II ACYW4 II34.9%850 26,5003,500900 70% 8 1,25020% 8 8 17 8

... 8 34.2% 29.0% 19.7% (1) (1) (1)... 46.6% 35.7% 31.4% (1) (1) (1)... 35.0% 24.3% 12.9% (1) (1) (2)... 18.0% 12.4% 8.1% (2) (3) (4) MENET 1881 6133512 65% 9

15 75% 60% 21,000 73% 4,20038,000

85%

20510 20[]

9 II54% 9 Frost & Sullivan II II II II

% % %... 841,334 59.5 1,230,340 51.4 1,167,767 43.8... 89,093 6.3 249,447 10.4 356,788 13.3... 930,427 65.8 1,479,787 61.8 1,524,555 57.1 51.4%43.8%Frost & Sullivan23.4% 10 6.9%10.7% II64% 1915 6 73%II 27% 48 10 IIII

... 33.3% 40.0% 37.9%... 31.4% 23.4% 27.5%... 24.5% 22.6% 20.2%... 7.4% 9.7% 9.5%... 3.4% 4.3% 4.9%... 100% 100% 100% 50

A+C AC

(i) (ii) (iii) (iv) 90 60180 1915 6

I II 15 II B 6 II B 6 II 35 II 1824 1 II 119 II I 8 II 24 I 3 II 63 II 3 II AC 35 II MF59-65 II 6 II

I II II PCECV III III 50.2% 37.9% 31.2% 2-8 48

100 20% 6.29.419.1

19 (Jiangsu Quality Control Society) 48 24

7,77812,972 28,500

2,800 542 11 73%II 87% 15% 90 6012028.4% 240 1.8%2.4% 11

542109

... 225 732,684 51.8 385 1,053,605 44.0 542 1,107,560 41.5... 66 197,743 14.0 105 426,182 17.8 109 416,995 15.6 12... 201 691,831 48.9 200 904,375 37.8 251 875,309 32.8... 57 149,503 10.6 66 325,965 13.6 80 292,458 11.0 60 120 90 12

8.7% 14 20,500 II (1) 114 (2) 14 Frost & Sullivan II II

... 89,093 6.3 249,447 10.4 356,788 13.3

62235 20,5001150 590%

II 015 II 16 A+C Meningococcal - 2 A+C 80 18 200 Meningococcal Meningococcal 2 ACYW -ACYW 200

20,500... 4,000 10,000 2,500... 8,000 18,000 20,500... 184,059 13.0 625,493 26.1 838,562 31.5... 299,499 21.2 289,758 12.1 304,861 11.4

396 26,5003,500 90070% 15 1,250 20% 15 3090 90 15

17 12.5%24.2%28.5% 36.6%63.2%66.6%................. MENET 34.2%19.7%74% 41% 1,788

MENET 46.6%31.4%48% 1,140,0001,656,00020.5% 309 MEMET 18.0%8.1% 407,000 760,00036.6% 706 507,000 1,487,00071.3%MEMET 35.0%12.9% 153

1,419,0006,930,000121.0% 1,186 2.4%0.1%...... PEG

AIDS-KS 50 80% 50 50 135169186 90

90

26.6 12.1822.1315.92 GMP

... 2 74.8 2 100 2 120... 2 32.5 2 65 2 80

(1)... 1 150 113 75.4%... 2 20 15.5 78.9% (1) 3008 30022 1563 44 15 27 15YilingYiliang 2710 15

16 0.3 Kaifufei 15.8 Clindamycin 0.6 Kaifufei 26.9 phosphate 0.9 Kaifufei 36.6 1.2 Kaifufei 45.7 15 Zhuoao 9.9 Ambroxol 30 Zhuoao 17.0 0.5 57.7 Aztreonam 1.0 98.1 2.0 Suqunan 166.8 0.6 Haifujia 21.0 Amoxicillin 1.2 Haifujia 38.0 Clavulanate acid 0.2 2.0 Amikacin 0.4 Kaifusheng 4.4 13.3%6.6%7.4% 4.5%2.5%3.2% 80% 20% 80:20 16

800,000 800,000 50 60 210.2224.7 211.4 Quetiapin FumarateClindamycin phosphate AmbroxolLevofloxacin 30 45 Quetiapin Fumarate []

2.43.75.1

29.1%28.5%22.1% 9.9%9.1% 7.3% 542109 17 2,80020,500 13.4%2.4% 17 88.4%85.9%97.8% 17

67.2% 70.4% 65.5% State Pharmaceutical (Holdings) Limited Frost & SullivanII IMS 63.4%65.6%60.7% 44.1%46.6%46.5% 67.2%70.4%65.5%

7.9 Frost & SullivanZuellig Pharma Asia Pacific10Frost & Sullivan 250150

Frost & Sullivan31.3% 39.3% Frost & Sullivan 4%200 715 Frost & Sullivan Frost & Sullivan 4873 23.3%

19 GSP20 (i)(ii)

20 6221,055 1,201... 446 37.1%... 383 31.9%... 229 19.1%... 82 6.8%... 61 5.1%... 1,201 100.0% 56.789.0154.7 4.0%3.7%5.8%

570,000 60,000 B.

107,920.04 27,031.22 35.8 27,031.22 107,920.04 1911,735.8

II i)iii ii)iiiii iii) II

No.1 Hualing Street II6840 371 II III6840 6845 6864 6865 GMP GMP II

IIIII 171